Skip to content

FP7H2020HORIZON

Boehringer Ingelheim Internationalgmbh

Country
DEGermany
Defence projects
0
Projects, all programmes
50
As coordinator
1
EU contribution (CORDIS)
EUR 13,000
Active
2008 to 2025

Projects

50 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
EPADEuropean Prevention of Alzheimer’s Dementia ConsortiumFP72015ParticipantNot stated
ADAPT-SMARTAccelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: 115890H20202015ParticipantEUR 0
IPIEIntelligent Assessment of Pharmaceutical in the EnvironmentFP72015ParticipantNot stated
CANCER-IDCancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in bloodFP72015ParticipantNot stated
AETIONOMYAetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and TherapyFP72014ParticipantNot stated
SPRINTTSarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategiesFP72014ParticipantNot stated
GETREALIncorporating real-life clinical data into drug developmentFP72013ParticipantNot stated
EMIFEuropean Medical Information FrameworkFP72013ParticipantNot stated
EUPATIEuropean Patients' Academy on Therapeutic InnovationFP72012ParticipantNot stated
DIRECTDIabetes REsearCh on patient sTratificationFP72012ParticipantNot stated
COMPACTCollaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular TargetsFP72012ParticipantNot stated
ALEXANDERMucus Permeating Nanoparticulate Drug Delivery SystemsFP72012ParticipantNot stated
STEMBANCCStem cells for Biological Assays of Novel drugs and prediCtive toxiCology (StemBANCC)FP72012ParticipantNot stated
ORBITOOral biopharmaceutics toolsFP72012ParticipantNot stated
PREDECTNew Models for Preclinical Evaluation of Drug Efficacy in Common Solid TumoursFP72011ParticipantNot stated
BTCUREBeTheCuREFP72011ParticipantNot stated
ONCOTRACKOncoTrack - Methods for systematic next generation oncology biomarker developmentFP72011ParticipantNot stated
IMIDIAImproving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetesFP72010ParticipantNot stated
SAFESCIMETEuropean Modular Education and Training Programme in Safety Sciences for MedicinesFP72010ParticipantNot stated
MARCARbioMARkers and molecular tumor classification for non-genotoxic CARcinogenesisFP72010ParticipantNot stated

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.